Rulings Help Address Confusion of 2009 Biosimilar Approval Pathway Law
Aug 20, 2015 | | Corporate Governance, Drug policy, Health Law, Law, Legislation, PharmaceuticalsThe Federal Circuit Court of Appeals issued two rulings related to the Biologics Price Competition and Innovation Act of 2009 (“BPCIA”), a law that established an abbreviated regulatory approval process for follow-on biological products, also ref